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The deoxynucleoside triphosphate triphosphohydrolase SAMHD1 is a myeloid cell-specific retroviral restric-
tion factor that can be inactivated by viral protein Vpx from HIV-2 and certain SIV. In this issue of Cell Host &
Microbe, Kyei et al. (2015) report that cyclin L2 enhances HIV-1 infection in macrophages by regulating
SAMHD1.The worldwide epidemic of AIDS is
caused by HIV-1 and HIV-2 infections,
which still lack both a cure and a vaccine.
HIV-2 and closely related SIV from ma-
caques and sooty mangabeys (SIVmac/
SIVsmm), but not HIV-1, encode a virion-
associated protein, Vpx (Yu et al., 1988).
Earlier work has indicated that Vpx is crit-
ical for the replication of HIV-2/SIVmac in
myeloid cells such as macrophages (Yu
et al., 1991) and dendritic cells (Goujon
et al., 2006). Recently, the SAM domain
and HD domain-containing protein
(SAMHD1) was discovered to be a
myeloid-specific restriction factor against
retroviruses, including HIV-1, SIVmac,
and Vpx-deficient HIV-2 (Hrecka et al.,
2011; Laguette et al., 2011). SAMHD1,
the only knownmammalian deoxynucleo-
side triphosphate triphosphohydrolase
(dNTPase), had previously been shown
to contribute to innate immune responses,
and its genetic mutations are associated
with the rare inherited disease Aicardi-
Goutie`res syndrome (Rice et al., 2009).
SAMHD1 suppresses the replication of
various retroviruses, including HIV-1, in
myeloid cells through its dNTPase activity
(Lahouassa et al., 2012). In macrophages,
dendritic cells, and resting CD4+ T cells,
dNTP levels are significantly decreased
in the presence of SAMHD1, thereby pre-
senting a barrier to viral reverse transcrip-
tion (Lahouassa et al., 2012). However,
the dNTPase activity of SAMHD1 is not
sufficient to account for the SAMHD1-
mediated inhibition of HIV-1. Although
the phosphorylation status of SAMHD1
at position T592 does not influence its
dNTPase activity, it is nevertheless critical
for suppressing HIV-1 in a differentiated8 Cell Host & Microbe 17, January 14, 2015 ªmacrophage cell line (U937) (White et al.,
2013).
In order to replicate in myeloid cells,
HIV-2/SIV strains have evolved to use
their viral protein, Vpx (Figure 1), to inacti-
vate SAMHD1 (Hrecka et al., 2011; Lagu-
ette et al., 2011). Although it lacks Vpx,
HIV-1 can readily replicate in macro-
phages. Whether HIV-1 has a strategy to
overcome SAMHD1 remains an open
question. In this issue of Cell Host &
Microbe, Kyei et al. (2015) have identified
the cell cycle regulator cyclin L2 as a pu-
tative host factor that appears to be uti-
lized by HIV-1 to neutralize SAMHD1 in
macrophages (Kyei et al., 2015).
Kyei et al. first identified cyclin L2
(CCNL2) as a major determinant of HIV-1
infection in a non-dividing differentiated
macrophage cell line (THP-1) and primary
macrophages (Kyei et al., 2015). In con-
trast, cyclin L2 had no apparent effect
on HIV-1 infection in cycling cells such
as HEK293T or HeLa cells. Kyei et al.
made the unexpected discovery that cy-
clin L2 binds SAMHD1 and triggers its
degradation through the proteasome
pathway (Figure 1). Cyclin L2 recruits the
cellular factors DCAF1, DDB1, and Cul4
to form a E3 ubiquitin ligase (CRL4-
DCAF1) in order to induce the degrada-
tion of SAMHD1 (Figure 1). Interestingly,
cyclin L2-mediated SAMHD1 regulation
is very similar to Vpx-induced SAMHD1
degradation (Figure 1), which also en-
gages the cellular CRL4-DCAF1 E3 ligase
(Hrecka et al., 2011; Laguette et al., 2011).
The study by Kyei et al. raises several
interesting questions. HIV-1 infection in
macrophages (differentiated THP-1 cells)
results in the depletion of SAMHD1 in a2015 Elsevier Inc.cyclin L2-dependent manner. However,
it is not clear how HIV-1 infection manipu-
lates cyclin L2 expression to downregu-
late SAMHD1. The HIV-1 accessory pro-
tein Vpr has been reported to enhance
HIV-1 replication in macrophages (Con-
nor et al., 1995). Like cyclin L2 and
Vpx, Vpr also engages CRL4 (DCAF1).
Whether Vpr influences cyclin L2 function
is an intriguing question.
In addition to regulating the expression
of SAMHD1, cyclin L2 may also enhance
viral replication in a SAMHD1-indepen-
dent fashion, since knocking down cyclin
L2 was also found to increase Vpx-con-
taining HIV-2 infection in macrophages.
Cyclin L2 normally associates with RNA
polymerase II and is involved in pre-
mRNA splicing. Whether cyclin L2 regu-
lates HIV mRNA splicing in macrophages
is not yet clear.
Although HIV-1 could manipulate cyclin
L2 in macrophages to enhance viral repli-
cation, it is generally thought that HIV-1
does not productively infect dendritic
cells. Why HIV-1 cannot overcome
SAMHD1 in dendritic cells is not clear.
On the other hand, Vpx expression readily
enhances HIV-1 in dendritic cells. One
could speculate that HIV-1 cannot utilize
cyclin L2 to inactivate SAMHD1 in den-
dritic cells, or cyclin L2 may not be able
to regulate SAMHD1 in these cells.
Clearly, the role of cyclin L2 during HIV-1
infection in dendritic cells requires further
investigation.
Why does HIV-1 overcome SAMHD1
through the cyclin L2-dependent pathway
and not Vpx? The suppressive effect of
SAMHD1 on HIV-1 infection in macro-
phagescannot be fully overcomebycyclin
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Figure 1. HIV-1/HIV-2 Subvert SAMHD1 through Different Adaptors of the CRL4-DCAF1 E3 Ligase
(A) Unlike HIV-2/SIVMAC, HIV-1 genome does not contain Vpx coding sequences.
(B) Vpx, as a virion-associated protein, plays a critical role in the early step of HIV-2/SIV infection (right). Vpx recognizes and loads SAMHD1 onto CRL4 (DCAF1)
E3 ubiquitin ligase for proteasome degradation. During HIV-1 infection (left), cyclin L2 expression is modulated. In turn, cyclin L2 recruits CRL4 (DCAF1) to induce
SAMHD1 degradation. Bymanipulation of the abundance of SAMHD1 protein through distinct mechanisms, HIV-1 andHIV-2/SIVmac viruses are able to replicate
in macrophages despite their genomic differences.
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fect beneficial for HIV-1 replication? The
lower level of HIV-1 production in macro-
phages could be a strategy to avoid host
immune responses, unlike that of Vpx-
containing HIV-2/SIV viruses. Previous
data have shown that HIV-1 infection
does not trigger the innate DNA sensing
pathway mediated by cGAS-STING in
macrophages. However, HIV-1 infection
does trigger such immune responses in
Vpx-VLP-pretreated macrophages.
In conclusion, the study by Ratner and
his research team (Kyei et al.) has made
an important contribution to our under-
standing of the possible mechanism(s)
by which HIV-1 evades SAMHD1 restric-
tion. Macrophages contribute to HIV
pathogenesis by acting as a major player
during viral transmission and a potential
viral reservoir in tissues. Unlike HIV-2
and many SIV lineages, HIV-1 does not
encode Vpx/Vpr to neutralize SAMHD1directly. The strategy used by HIV-1 to
subvert SAMHD1 in macrophages is
another example of the amazing diversity
of viral counter-measures against various
host restriction factors.
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